lung cancer

Research Reports

Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices

02/09/2024

Adrien Moucquot ;

Poka Cui ;

Heather Moses ;

David Dellamonica ;

Peter Blanshard ;

María Teresa Campos-Partera ;

Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...

Poka Cui and colleagues...

02/09/2024

Journal of Clinical Pathways

News

Higher Out-of-Pocket Costs Associated With Decreased TKI Adherence in NSCLC

02/15/2021

Journal of Clinical Pathways

News

Timely Specialty Palliative Care for NSCLC Associated With Cost-Savings

12/17/2020

Journal of Clinical Pathways

Guideline Updates

Multiple Treatment Guideline Updates Released for Lung Cancer

05/19/2020

The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...

The...

05/19/2020

Journal of Clinical Pathways

Guideline Updates

Managing Lung Nodules, Lung Cancer Screening During the Pandemic

05/12/2020

A new expert panel consensus statement offers guidance for clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. The statement was published jointly in...

A new...

05/12/2020

Journal of Clinical Pathways

Research Reports

Drug Costs vs Probability of Survival in Lung Cancer: Impact of Dosage, Duration, and Immune Checkpoint Inhibitor Combinations

06/18/2019

Helmy M. Guirgis , MD, PhD;

Abstract: Clinical guidelines and pathways recommend use of immune checkpoint inhibitors (ICI) in first- and second-line treatment of advanced/metastatic non-small cell lung cancer (amNSCLC). There is an unmet need...

...

06/18/2019

Journal of Clinical Pathways

Research in Review

SBRT Deemed Safe and Effective in Older Patients With Lung Cancer

07/19/2017

JCP Editors

Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...

...

07/19/2017

Journal of Clinical Pathways

Research in Review

Model Predicts Tumor Spread in Lung Cancer

07/17/2017

JCP Editors

Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

Lung Cancer Screening Is Cost-Effective, Identifies Other Conditions in High-Risk Patients

07/03/2017

JCP Editors

Analysis of high-risk lung cancer screening shows that screening is cost-effective and may offer cost savings if noncurative treatment costs continue to rise, according to new research published in the Journal of...

...

07/03/2017

Journal of Clinical Pathways

Research in Review

New Prognostic Model Accurately Predicts Survival in Lung Cancer With Brain Metastases

06/28/2017

JCP Editors

A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...

A new...

06/28/2017

Journal of Clinical Pathways